טוען...
My Patient Taking A Novel Oral Anticoagulant Needs Surgery, Device Implantation, Or Ablation
Atrial fibrillation (AF) is a highly prevalent chronic condition and a growing number of patients are on chronic anticoagulation therapy with novel oral anticoagulant (NOAC) agents: dabigatran, rivaroxaban, and apixaban. Many of these patients are expected to require invasive procedures. There is no...
שמור ב:
| הוצא לאור ב: | J Atr Fibrillation |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Cardiofront, Inc
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4956294/ https://ncbi.nlm.nih.gov/pubmed/27957125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.1145 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|